Uppsala University
Uppsala, 75185, Sweden
NCT Number: NCT03072745
The aim of the present study is to examine cognitive function in a patient population with complex chronic pain to test the hypothesis that insomnia severity on its own predicts objective cognitive function, and that a correlation is not better explained by comorbid depression or anxiety, morphine equivalent daily dose, or the level of pain itself.
Looking for future studies?
Notify Me18 year–65 year
All sexes
Interventional
Not applicable
Uppsala, 75185, Sweden
Almost 20 % of the adult European population suffers from chronic pain of moderate to severe intensity, and clinical insomnia has been reported in 53-73% of chronic pain patients. Insomnia seems to be correlated with small to moderate impairments in several cognitive functions involved in working and episodic memory and in attention tasks, and chronic pain has been shown to be associated with objective deficits in memory and executive functioning. The aim of the present study is to examine cognitive function in a patient population with complex chronic pain to test the hypothesis that insomnia severity on its own predicts objective cognitive function, and that a correlation is not better explained by comorbid depression or anxiety, morphine equivalent daily dose, or the level of pain itself.
Inividuals with complex chronic pain are assessed with a neuropsychological test battery examining different aspects of memory and executive functioning:
The Digit Span subtest from Wechsler's Adult Intelligence Scale III (WAIS-III): Verbal working memory.
Claeson-Dahl Inventory of Learning and Memory (CD): Verbal retention. The Rey Complex Figure Test (RCFT): Visuospatial retention. The Wisconsin Card Sorting Test (WCST): Cognitive flexibility. The Trail-Making Test (TMT): Sustained attention.
The presence of insomnia is examined with the Bergen Insomnia Scale (BIS) , and insomnia severity with the Insomnia Severity Index (ISI). Present pain level at the time of the neuropsychological assessment is quantified using the Visual Analogue Scale (VAS). Pain medication is transformed to the morphine equivalent daily dose (MEDD). Anxiety and depression are assessed with the Hospital Anxiety and Depression Scale.
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
Assessment with a neuropsychological test battery examining different aspects of memory and executive functioning
Time frame: 1 day
Composite score comprising verbal working memory, verbal retention, and visuospatial retention.
Time frame: 1 day
Composite score comprising cognitive flexibility and sustained attention.
Uppsala University
Other
Distinct Effect of Insomnia on Cognitive Performance in Individuals With Complex Chronic Pain
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT05147974
Chronic Pain, Dyssomnias
Toronto, Ontario, Canada
View Trial DetailsNCT06353100
Anxiety Disorders, Behavior
Santiago, RM, Chile
View Trial DetailsNCT06368531
Chronic Pain, Dyssomnias
Odense, Denmark
View Trial DetailsNCT04265586
Anxiety Disorders, Chronic Pain
Helsinki, Finland
View Trial Details